Influence of Cytarabine Metabolic Pathway Polymorphisms in Acute Myeloid Leukemia Induction Treatment

被引：0

作者：

Megias-Vericat, Juan Eduardo ^{[1
,2
]}

Pau, Montesinos ^{[3
]}

Herrero, Maria Jose ^{[2
,4
]}

Moscardo, Federico ^{[3
]}

Boso, Virginia ^{[2
,4
]}

Martinez-Cuadron, David ^{[3
]}

Rojas, Luis ^{[2
,4
]}

Rodriguez-Veiga, Rebeca ^{[3
]}

Hervas, David ^{[5
]}

Boluda, Blanca ^{[3
]}

Sendra, Luis ^{[4
]}

Sanz, Jaime ^{[6
]}

Miguel, Antonio ^{[4
]}

Cervera, Jose ^{[7
]}

Poveda, Jose Luis ^{[1
,2
]}

Alino, Salvador F. ^{[8
,9
,10
]}

Sanz, Miguel Angel ^{[3
]}

机构：

[1] Hosp Univ Politecn Fe, Dept Pharm, Drug Clin Area, Valencia, Spain

[2] Inst Invest Sanitaria Fe, Valencia, Spain

[3] Hosp Univ Politecn Fe, Dept Hematol, Valencia, Spain

[4] Hosp Univ Politecn Fe, Pharmacogenet Unit, Drug Clin Area, Valencia, Spain

[5] Inst Invest Sanitaria Fe, Biostatist Unit, Valencia, Spain

[6] Hosp Univ Politecn Fe, Valencia, Spain

[7] Hosp Univ Politecn Fe, Genet Unit, Hematol Serv, Valencia, Spain

[8] Univ Valencia, Pharmacogenet Unit, Drug Clin Area, Valencia, Spain

[9] Univ Valencia, Clin Pharmacol Unit, Hosp Univ Politec Fe, Valencia, Spain

[10] Univ Valencia, Fac Med, Dept Pharmacol, Valencia, Spain

来源：

BLOOD | 2016年 / 128卷 / 22期

关键词：

D O I：

10.1182/blood.V128.22.5130.5130

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

5130

引用

页数：6

共 50 条

[31] Mitoxantrone and etoposide with or without intermediate dose cytarabine for the treatment of primary induction failure or relapsed acute myeloid leukemia
Trifilio, Steven M.
Rademaker, Alfred W.
Newman, Diane
Coyle, Katherine
Carlson-Leuer, Katrin
Mehta, Jayesh
Altman, Jessica
Frankfurt, Olga
Tallman, Martin S.
[J]. LEUKEMIA RESEARCH, 2012, 36 (04) : 394 - 396
[32] Intensive induction chemotherapy with regimen containing intermediate dose cytarabine in the treatment of de novo acute myeloid leukemia
Liu, Jiazhuo
Mi, Yingchang
Fu, Mingwei
Yu, Wenjuan
Wang, Ying
Lin, Dong
Bian, Shougeng
Wang, Jianxiang
[J]. AMERICAN JOURNAL OF HEMATOLOGY, 2009, 84 (07) : 422 - 427
[33] Induction treatment of acute myeloid leukemia in an elderly patient with intramarrow injection/administration of cytarabine: first report of a case
Islam, Anwarul
[J]. CLINICAL CASE REPORTS, 2015, 3 (12): : 1026 - 1029
[34] Efficient Knock-out of Serine Protease Cathepsin G Enhances Chemosensitivity to Cytarabine By Modulating the Cytarabine Metabolic Pathway Genes in Acute Myeloid Leukemia
Das, Saswati
Illangeswaran, Raveen Stephen Stallon
Jebanesan, Daniel Zechariah Paul
Benjamin, Esther Sathya Bama
Vidhyadharan, Rakhi Thalayatta
Mathews, Vikram
Velayudhan, Shaji Ramachandran
Balasubramanian, Poonkuzhali
[J]. BLOOD, 2022, 140 : 11542 - 11542
[35] Cytarabine and skin reactions in acute myeloid leukemia
Grille, Sofia
Guadagna, Regina
Boada, Matilde
Irigoin, Victoria
Stevenazzi, Mariana
Guillermo, Cecilia
Diaz, Lilian
[J]. MEDICINA-BUENOS AIRES, 2013, 73 (06) : 535 - 538
[36] Cytarabine Dose for Acute Myeloid Leukemia REPLY
Lowenberg, Bob
[J]. NEW ENGLAND JOURNAL OF MEDICINE, 2011, 364 (22) : 2168 - 2169
[37] Cellular Response to Cytarabine Is Modulated by the DNA Mismatch Repair Pathway: Implications for Treatment of Acute Myeloid Leukemia.
Fordham, Sarah E.
Matheson, Elizabeth C.
Scott, Kathryn
Irving, Julie
Allan, James M.
[J]. BLOOD, 2010, 116 (21) : 760 - 760
[38] Optimal dosing of cytarabine in induction and post-remission therapy of acute myeloid leukemia
Roland B. Walter
Frederick R. Appelbaum
Elihu H. Estey
[J]. Leukemia, 2021, 35 : 295 - 298
[39] Optimal dosing of cytarabine in induction and post-remission therapy of acute myeloid leukemia
Walter, Roland B.
Appelbaum, Frederick R.
Estey, Elihu H.
[J]. LEUKEMIA, 2021, 35 (02) : 295 - 298
[40] Efficacy and Toxicity of Induction Therapy with Cladribine, Idarubicin, and Cytarabine (IAC) for Acute Myeloid Leukemia
Woelich, Susan K.
Braun, James T.
Schoen, Martin W.
Ramlal, Reshma
Freter, Carl E.
Petruska, Paul J.
Lionberger, Jack M.
[J]. ANTICANCER RESEARCH, 2017, 37 (02) : 713 - 717

← 1 2 3 4 5 →